Cabaletta Bio to Participate in Upcoming Investor Conferences in September
Provided By GlobeNewswire
Last update: Aug 28, 2024
PHILADELPHIA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases, today announced that the Company will participate in the following investor conferences in September:
NASDAQ:CABA (6/2/2025, 12:08:54 PM)
2.035
+0.17 (+8.82%)
Find more stocks in the Stock Screener
CABA Latest News and Analysis
17 days ago - ChartmillTop movers in Friday's pre-market sessionDiscover the top movers in Friday's pre-market session and stay informed about market dynamics.
18 days ago - ChartmillThese stocks are gapping in today's sessionTraders are paying attention to the gapping stocks in Thursday's session. Let's dive into which stocks are experiencing notable gaps.
